InMed Pharmaceuticals Inc. (INM)
NASDAQ: INM · IEX Real-Time Price · USD
0.292
+0.011 (3.77%)
Jul 26, 2024, 3:52 PM EDT - Market closed
InMed Pharmaceuticals Market Cap
InMed Pharmaceuticals has a market cap or net worth of $2.57 million as of July 26, 2024. Its market cap has decreased by -22.03% in one year.
Market Cap
2.57M
Enterprise Value
-4.73M
1-Year Change
-22.03%
Ranking
Category
Stock Price
$0.29
Market Cap Chart
Since November 16, 2020, InMed Pharmaceuticals's market cap has decreased from $26.00M to $2.57M, a decrease of -90.10%. That is a compound annual growth rate of -46.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 26, 2024 | 2.40M | 9.09% |
Dec 29, 2023 | 2.20M | 15.79% |
Dec 30, 2022 | 1.90M | -89.73% |
Dec 31, 2021 | 18.50M | -19.57% |
Dec 31, 2020 | 23.00M | -11.54% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Revelation Biosciences | 2.65M |
Altamira Therapeutics | 2.64M |
NovaBay Pharmaceuticals | 2.62M |
Tivic Health Systems | 2.52M |
Aclarion | 2.51M |
Heart Test Laboratories | 2.46M |
Cyclacel Pharmaceuticals | 2.46M |
FOXO Technologies | 2.44M |